<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>E药经理人 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-31T23:31:46+08:00</updated>
  <subtitle>我们致力于成为医药行业意见领袖平台，我们记录和观察医药重大商业事件，展现这个行业的复杂和冲突，提供最前线的思想火花。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>未盈利biotech们玩起投资“游戏”，君实领衔，百济、康希诺进场</title>
    <updated>2020-12-31T21:31:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/1RM82Dl02cME4pDYELoRVA</id>
    <link href="https://mp.weixin.qq.com/s/1RM82Dl02cME4pDYELoRVA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年，我们和20位行业大咖聊了这些……</title>
    <updated>2020-12-31T21:31:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/-mBC-8Ovmh6lIOq9JSZRzg</id>
    <link href="https://mp.weixin.qq.com/s/-mBC-8Ovmh6lIOq9JSZRzg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>以创新研发打造生产力 康弘药业构建国际化蓝图</title>
    <updated>2020-12-31T21:31:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/smVo-Hb4dSDKWO7HfQlG3A</id>
    <link href="https://mp.weixin.qq.com/s/smVo-Hb4dSDKWO7HfQlG3A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>影响所有药企！遗传办确认形审无需提交伦理批件，伦理审查和遗传办审批平行进行！</title>
    <updated>2020-12-31T21:31:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/K3iULfUkpT5ekudIRWolsQ</id>
    <link href="https://mp.weixin.qq.com/s/K3iULfUkpT5ekudIRWolsQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>信息量太大！医保专家深度揭秘谈判底价由来！PD-(L)1谈判专家说：表情管理很重要！</title>
    <updated>2020-12-30T16:52:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/dz-SPedxSe9j17zoxnUbeQ</id>
    <link href="https://mp.weixin.qq.com/s/dz-SPedxSe9j17zoxnUbeQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>刚发布就火出圈，这支MV凭什么？----国内首个医药企业乐队C位出道</title>
    <updated>2020-12-30T16:52:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/nImtot_ldPiN46LcvMXwuQ</id>
    <link href="https://mp.weixin.qq.com/s/nImtot_ldPiN46LcvMXwuQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>豪森药业创新药孚来美纳入国家医保目录，全球首款PEG化的长效降糖药周制剂</title>
    <updated>2020-12-30T16:52:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/fmWh-L4ti2xlpz1yat9fcw</id>
    <link href="https://mp.weixin.qq.com/s/fmWh-L4ti2xlpz1yat9fcw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【重磅直播】“改变生态”——2020’中国医药十家新生态公司跨年访谈</title>
    <updated>2020-12-30T16:52:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/0Fc3f-yPDKHtHtsuNKzS4w</id>
    <link href="https://mp.weixin.qq.com/s/0Fc3f-yPDKHtHtsuNKzS4w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医保谈判落幕：诺华积极罗氏失落，石药、豪森勇于牺牲，百济、再鼎不遗余力......</title>
    <updated>2020-12-29T20:21:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/zRBV9IUkg-FlvS9cG1JSsQ</id>
    <link href="https://mp.weixin.qq.com/s/zRBV9IUkg-FlvS9cG1JSsQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>最新医保目录发布！119种通过谈判，先声药业先必新纳入</title>
    <updated>2020-12-29T20:21:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/uDZe9-JoZWhk0Gt6mWsHvw</id>
    <link href="https://mp.weixin.qq.com/s/uDZe9-JoZWhk0Gt6mWsHvw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>知名上市药企诚挚招聘！</title>
    <updated>2020-12-29T20:21:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/wCiNMVFaepIHNK5NRx_Rig</id>
    <link href="https://mp.weixin.qq.com/s/wCiNMVFaepIHNK5NRx_Rig" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【魔说】对医保目录理解越深，明年业绩才能走得越远</title>
    <updated>2020-12-29T20:21:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/f_HUs5_qtd9KWzG7xQXiiA</id>
    <link href="https://mp.weixin.qq.com/s/f_HUs5_qtd9KWzG7xQXiiA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新战役已经打响！恒瑞、君实、百济PD-1全适应证均纳入医保，外资集体出局！971谈判失败！新目录3月1日起执行</title>
    <updated>2020-12-28T11:50:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/aBrFS845xofZ5yTLn_akjg</id>
    <link href="https://mp.weixin.qq.com/s/aBrFS845xofZ5yTLn_akjg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>罗永庆离开吉利德后首次亮相，详解为何二次创业？为什么是腾盛博药？</title>
    <updated>2020-12-27T18:47:28+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-27:/s/Vvlo6e8jX3agosjN89qBLg</id>
    <link href="https://mp.weixin.qq.com/s/Vvlo6e8jX3agosjN89qBLg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>中药发展找“魂”！现代化是不是伪命题？怎么做到守正创新？</title>
    <updated>2020-12-27T18:47:28+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-27:/s/Jk3dUC17T-Cse5VVaVP4pA</id>
    <link href="https://mp.weixin.qq.com/s/Jk3dUC17T-Cse5VVaVP4pA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>广东药品带量采购前夜：全省挂网价格统一！</title>
    <updated>2020-12-27T18:47:28+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-27:/s/jAvz6QVH0-WSbHGwR00w2g</id>
    <link href="https://mp.weixin.qq.com/s/jAvz6QVH0-WSbHGwR00w2g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【魔说】2020终要过去！最能概括今年医药行业的10个关键词，哪个正在深刻影响你？</title>
    <updated>2020-12-26T18:15:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-26:/s/aadQ6Q2VimPAXU3OQ0I3fw</id>
    <link href="https://mp.weixin.qq.com/s/aadQ6Q2VimPAXU3OQ0I3fw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医保谈判药品单列门诊统筹支付的利弊分析</title>
    <updated>2020-12-26T18:15:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-26:/s/IQvrKdlZVoUdcEEdCNTa5Q</id>
    <link href="https://mp.weixin.qq.com/s/IQvrKdlZVoUdcEEdCNTa5Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>平均降价93%的冠脉支架集采落地，步入“百元时代”的高值耗材，质量该如何保证？</title>
    <updated>2020-12-25T21:12:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/tEDVDoxL90dQtZshX8ndOw</id>
    <link href="https://mp.weixin.qq.com/s/tEDVDoxL90dQtZshX8ndOw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>成立不足5年融资超10亿元 这家CRO公司凭什么？</title>
    <updated>2020-12-25T21:12:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/Lcr8iO-wpEciTEigRZKBDA</id>
    <link href="https://mp.weixin.qq.com/s/Lcr8iO-wpEciTEigRZKBDA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>